HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis.

Abstract
The challenge for the treatment of inflammatory bowel disease (IBD) is the delivery of the drug to the site of inflammation. Because nanoparticles have the ability to accumulate in inflamed regions, the aim of the present study was to evaluate nanostructured lipid carriers (NLCs) as nanoparticulate drug delivery systems for the treatment of IBD. Budesonide (BDS) was chosen as a candidate anti-inflammatory drug. BDS-loaded NLCs (BDS-NLC) produced by high-pressure homogenization had a size of 200 nm and a negative zeta potential. BDS-NLCs reduced the TNF-α secretion by activated macrophages (J774 cells). BDS-NLCs were more active in a murine model of dextran sulfate-induced colitis when compared with Blank-NLCs or a BDS suspension: BDS-NLCs decreased neutrophil infiltration, decreased the levels of the pro-inflammatory cytokines IL-1β and TNF-α in the colon and improved the histological scores of the colons. These data suggest that NLCs could be a promising alternative to polymeric nanoparticles as a targeted drug delivery system for IBD treatment.
AuthorsAna Beloqui, Régis Coco, Mireille Alhouayek, María Ángeles Solinís, Alicia Rodríguez-Gascón, Giulio G Muccioli, Véronique Préat
JournalInternational journal of pharmaceutics (Int J Pharm) Vol. 454 Issue 2 Pg. 775-83 (Oct 01 2013) ISSN: 1873-3476 [Electronic] Netherlands
PMID23694806 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier B.V. All rights reserved.
Chemical References
  • Anti-Inflammatory Agents
  • Drug Carriers
  • Interleukin-1beta
  • Lipids
  • Tumor Necrosis Factor-alpha
  • Budesonide
  • Dextran Sulfate
  • Peroxidase
Topics
  • Animals
  • Anti-Inflammatory Agents (administration & dosage, chemistry)
  • Budesonide (administration & dosage, chemistry)
  • Cell Line
  • Colitis (chemically induced, drug therapy, immunology, pathology)
  • Colon (drug effects, immunology, pathology)
  • Dextran Sulfate
  • Drug Carriers (administration & dosage, chemistry)
  • Female
  • Inflammation (chemically induced, drug therapy, immunology, pathology)
  • Interleukin-1beta (immunology)
  • Lipids (chemistry)
  • Mice
  • Mice, Inbred C57BL
  • Nanostructures (administration & dosage, chemistry)
  • Peroxidase (immunology)
  • Tumor Necrosis Factor-alpha (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: